Articles with the topic: clinical-trial

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

Dr Ed WildDecember 16, 2016

Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease

Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD

Dr Jeff CarrollSeptember 30, 2016

Deutetrabenazine for Huntington's disease: a positive trial but the FDA says no? Not exactly...

Deutetrabenazine for Huntington's disease: a positive trial but the FDA says no? Not exactly...

A new scientific paper & lots of headlines about deutetrabenazine, a twist on treating chorea in Huntington's disease

Dr Peter McColganAugust 17, 2016

Planting trees together: The 2016 Huntington's Disease Society of America Convention

Planting trees together: The 2016 Huntington's Disease Society of America Convention

HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore

Dr Jeff CarrollJune 13, 2016

Thinking clearly about the earliest symptoms of HD and which brain regions control them

Thinking clearly about the earliest symptoms of HD and which brain regions control them

HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD

Dr Tamara MaiuriApril 18, 2016

How NOT to write a news article about a clinical trial

How NOT to write a news article about a clinical trial

A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!

Dr Jeff CarrollMarch 11, 2016

Huntington's Disease Therapeutics Conference 2016 - day 2

Huntington's Disease Therapeutics Conference 2016 - day 2

Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference

Dr Jeff CarrollFebruary 28, 2016

Looking Past the Spin: Results from a Clinical Trial of Cysteamine

Looking Past the Spin: Results from a Clinical Trial of Cysteamine

Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.

Melissa ChristiansonDecember 18, 2015

Liftoff: First humans treated with gene silencing drugs for HD!

Liftoff: First humans treated with gene silencing drugs for HD!

Major Announcement: First HD patients treated with gene silencing drugs

Dr Jeff CarrollOctober 22, 2015